Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- On Holding sets 2029 financial targets, authorizes $1B share buyback
- Nasdaq reaches record high close, AI stocks rally
- Elmet Group signs tungsten offtake deal with Hemerdon Mine
- Meta bull case increasingly playing out, Mizuho says
Celsus Therapeutics (CLTX) Halted on LUDP
August 20, 2015 2:42 PM EDTCelsus Therapeutics (NASDAQ: CLTX) Halted on LUDP
... MoreUPDATE: Celsus Therapeutics (CLTX) Tests Session Highs, Now Up 250%
August 19, 2015 1:24 PM EDT(Updated - August 19, 2015 3:48 PM EDT)
Celsus Therapeutics (NASDAQ: CLTX) Tests Session Highs
Update:
After punching through highs at $2.50 Celsus Therapeutics advanced above $3.50 on the session, well ahead of its opening price of $1.00. Gains follow news Tuesday morning related to a $75... More
Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement
August 18, 2015 7:18 AM EDTCelsus Therapeutics Plc (NASDAQ: CLTX) and Volution Immuno Pharmaceuticals SA today announced that Celsus has entered into a securities purchase agreement for a private placement with a select group of investors, led by Deerfield, and including Venrock, Vivo Capital, Foresite Capital, New Enterprise Associates, QVT Financial, RA Capital Management and certain other institutional investors.
The closing of the private placement is subject to Celsus obtaining shareholder approval of the financing transaction and the previously announced acquisition by Celsus of Volution Immuno Pharmaceuticals at Celsus' General Shareholder Meeting on September 16, 2015, the closing of the acquisition... More
